natalizumab
biogen,pfizer
['#ms ', 'natalizumab']
1/2 in this poster presented at #ectrims2022 we show that #ms patients with #natalizumab develop a positive serology response to the #covid19 vaccine at the same level as hcs. 
We are exploring inflammatory CNS diseases at @Hadassah medical center. Focus on immunity, MS, NMO, and MOGAD. The lab is led by prof. Adi Vaknin-Dembinsky.